Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. - Wikidata - awgldk - TriplyDB

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

http://www.wikidata.org/entity/Q36103437

about

GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II Molecular biomarkers for the detection of metastatic colorectal cancer cells Guanylyl cyclase C as a biomarker in colorectal cancer Long noncoding RNA expression profile analysis of colorectal cancer and metastatic lymph node based on microarray data Previstage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer.Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer Previstage GCC test for staging patients with colorectal cancer.Current status of gene expression profiling to assist decision making in stage II colon cancer Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer.Immune cells: plastic players along colorectal cancer progression The uroguanylin system and human disease.Isolated tumor cells and circulating CK20 mRNA in pN0 colorectal cancer patients.Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes.Molecular staging individualizing cancer management.Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer.Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer GUCY2C molecular staging personalizes colorectal cancer patient management Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?Molecular staging of node negative patients with colorectal cancer.Good and complete responding locally advanced rectal tumors after chemoradiotherapy: where are the residual positive nodes located on restaging MRI?Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study Ex vivo sentinel node mapping in colon cancer combining blue dye staining and fluorescence imaging.Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer Lymph node staging in colorectal cancer: old controversies and recent advances.Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.Endoscopic tattooing of early colon carcinoma enhances detection of lymph nodes most prone to harbor tumor burden.MicroRNA-194 modulates epithelial-mesenchymal transition in human colorectal cancer metastasis Impact on Prognosis of Lymph Node Micrometastasis and Isolated Tumor Cells in Stage II Colorectal Cancer.Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.Overexpression of ADAM9 Promotes Colon Cancer Cells Invasion.Single Nucleotide Polymorphisms in Genes MACC1, RAD18, MMP7 and SDF-1a As Prognostic Factors in Resectable Colorectal Cancer.Recurrence in patients with stage I colorectal cancer.Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients.

P2860

Q24641833-00C2B1FE-420B-48AD-8C62-ED9C6EC9DDAA Q26765344-969FA327-6A80-45B1-82BC-B670B729B9D6 Q27002450-CCBDDA82-FBFC-4D8E-81C4-359A14FB7996 Q27011759-9D2CE3A2-A39E-4308-91C1-DFC25F1F9074 Q31100562-161F2E76-F21F-43C2-949F-045194F83C81 Q33427566-B190AEF5-09E5-4410-924E-3F92AEBC5724 Q33552969-5AD6068C-BC8D-4846-9512-A2D93CCEE107 Q33641600-CE21BE48-3E1B-4F44-AC07-AB0B8C4EDD93 Q33829763-3B926B98-E8F5-4B3C-A16C-37EDD26C250C Q33887066-EBF7FF9A-2A0B-4B0A-ABFC-83AE81DDF32A Q33898741-578658A2-430B-4CFB-8CE1-A1AA65B246AB Q33977304-84E0111C-5EF8-4945-93F1-44E151EBC5ED Q33985586-43AFB93D-0295-4ECE-B35C-F783C10F68FE Q34293073-C537A4A2-1505-47DB-8005-1B4B35D533E8 Q34767579-CDF2DC68-7AC6-40F5-A880-70ACDE2CC81A Q34988050-74B0C36D-8CB4-46D9-B3D9-6C6E23733F84 Q35155933-B52BBAD6-80F8-44D1-8ACF-F069B36D5786 Q35605899-4F1D65C9-40F5-4D35-B072-72E2C897739B Q35854173-703BBFFF-C951-4541-B6A8-81DD8292653D Q35924171-0536C09F-BF98-417D-9EEA-AE88E87FC5D2 Q36016596-2542B772-7579-4450-8F02-06EE8B0CAE0E Q36075255-A3FA4EBB-0700-4114-8F1A-E8709D0D7157 Q36336227-00AE2150-7BD0-420E-AAC0-AD7B7D8C6302 Q36547205-E37F15F6-4070-4340-822B-406BDDCF7104 Q36646525-12161329-6EA9-45E4-B6C8-17BACADBBC46 Q37017653-9B7D56B4-A466-4C3B-ACEA-51E14ADD6290 Q37277448-961C365F-8710-461B-9E9B-5B87E67525C7 Q37299527-046FD47F-4A03-443E-9951-9E6A272A6203 Q37372472-5269FBF7-6C49-4998-838B-BBC70FEF535A Q37408817-0F5F8606-02E9-41D4-A337-0CE738C0A2AF Q37520492-8B029A22-2BFC-4FFF-8133-4ADCA6AF5993 Q37587123-165CBF80-FE8F-444A-AD70-B80F5CF5F686 Q37607246-2CA322FE-251A-46AA-8531-9F23C7E66285 Q37682846-8D1AD213-B2E0-45BB-83AD-197785982869 Q38474003-01068D02-CBED-45A7-9073-8441BBA1FF1E Q39535135-8514EE3A-7B59-42AA-B3E1-C8277AB0EA21 Q39916438-B6C9ED99-EB2D-4640-B246-BBCF5B2E9B8C Q40109815-24313FA3-BD09-4045-A749-DBC8EDD28360 Q41520623-71BC50D9-2056-47E4-9052-CAFB56456D3A Q42720542-54B90F60-AF32-4329-9B17-3DC515498CA4

P2860

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

http://www.wikidata.org/entity/Q36103437

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Is occult lymph node disease i ...... ew of the relevant literature.

@ast

Is occult lymph node disease i ...... ew of the relevant literature.

@en

type

label

Is occult lymph node disease i ...... ew of the relevant literature.

@ast

Is occult lymph node disease i ...... ew of the relevant literature.

@en

prefLabel

Is occult lymph node disease i ...... ew of the relevant literature.

@ast

Is occult lymph node disease i ...... ew of the relevant literature.

@en

P1433

Q36103437-EC71D5A6-E093-4BA8-B4A7-FB40100CC164

P1476

Q36103437-F5C37DC0-3D2B-4BD7-AD20-CA11913EC823

P2093

Q36103437-50898EEE-31A0-476D-A0C2-F7F0C1E3529F

Q36103437-CB898EDA-19F5-427F-B4D1-9F8242876944

Q36103437-FE945E52-F62B-4305-86F5-D7C22EE6C058

P2860

Q36103437-03933B6D-EFF2-4A96-96AC-5D2500E065B0

Q36103437-0627AB61-9657-4E1D-8C91-7ADF03D47F5D

Q36103437-08C804A3-50E8-4A40-92BA-E7601431F18B

Q36103437-1660CB1B-4DA3-4C17-847E-D31BBC7E00EE

Q36103437-1BF55FC1-9BF8-45AE-A217-61726342774E

Q36103437-40D640C9-DBA8-4F9E-97E3-5E1ADF12AAF3

Q36103437-49216EE1-78D1-40C3-9817-6224F61CD298

Q36103437-4D6D8F41-71AB-4506-BD0F-1E3EDA0F99BB

Q36103437-5175BB0C-6309-47D6-B35D-2E336D3D3199

Q36103437-556FB244-5C68-4744-8685-5A08022A718A

P304

Q36103437-9E29E0DC-8AD2-4D2E-9F11-73BB756F1795

P31

Q36103437-658CB5C0-6074-47FC-A835-E334280D3335

P356

Q36103437-138523A3-3E27-4AFE-82E8-470C3FC0D69F

P433

Q36103437-AEA0D002-B78D-4208-9A45-3D08466B4E47

P478

Q36103437-04485F81-0B86-43F9-8219-4003E226722D

P50

Q36103437-1793B438-E036-42D1-8F5D-3345A366005C

P577

Q36103437-0D03F7DA-FDA2-4C57-8807-5069A9DE3657

P5875

Q36103437-24BA675D-FF41-4908-BCAF-9EBD455271D3

P698

Q36103437-04C018F3-974E-439D-B70C-90F23AEEF258

P921

Q36103437-0A7EA0A8-9EA2-4FE2-86EC-6918D6B9E551

Q36103437-263026D6-958C-484F-922E-62B3D25905FF

Q36103437-33587679-45F0-45BF-AD0A-7E45A318E5A6

P932

Q36103437-BDB3AC71-9A64-4685-B172-D1AC1C397A3D

P356

JMOLDX.2007.070032

P1433

The Journal of Molecular Diagnostics

P1476

Is occult lymph node disease i ...... iew of the relevant literature

@en

P2093

Daniel G Nicastri

http://www.w3.org/2001/XMLSchema#string

John T Doucette

http://www.w3.org/2001/XMLSchema#string

Steven J Hughes

http://www.w3.org/2001/XMLSchema#string

P2860

American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group.

Prognostic significance of micrometastasis in non-small-cell lung cancer.

The clinical significance of axillary lymph node micrometastases in breast cancer.

Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer?

RT-PCR and immunohistochemical evaluation of sentinel lymph nodes after in vivo mapping with Patent Blue V in colon cancer patients.

Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study.

Preoperative radiotherapy improves survival for patients undergoing total mesorectal excision for stage T3 low rectal cancers.

The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.

Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins.

Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.

P304

563-571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/JMOLDX.2007.070032

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5927638

http://www.w3.org/2001/XMLSchema#string

P698

17916603

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2049052

http://www.w3.org/2001/XMLSchema#string